课题基金 / 基金详情

Role of AML1/Runx1 isoforms in development, self-renewal and differentiation of haematopoietic progenitor/stem cells

Role of AML1/Runx1 isoforms in development, self-renewal and differentiation of haematopoietic progenitor/stem cells
AML1/Runx1亚型在造血祖细胞/干细胞发育、自我更新和分化中的作用
批准号:
G0500950/1
负责人:
Alexander Medvinsky
金额:
$59.65万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2006
资助国家:
英国
项目状态:
已结题
起止时间:
2006 至 --

项目摘要

项目成果

Alexander Medvinsky的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The main focus of this research proposal is in the development and regulation of blood stem cells by a gene called AML1/Runx1. Stem cells are one of the main foci of current biology due to their potential to self-replicate and give rise to a variety of mature cells. AML1/Runx1 is critically important for the development of the adult blood system and is frequently involved in the development of human leukaemias. AML1/Runx1 gene produces different forms of the protein which can compete for the influence on other genes which are involved in stem cell development and function as well in the development of leukaemias. We have generated genetically altered embryonic stem (ES) cells and mouse experimental systems which allow AML1/Runx1 gene to be artificially regulated. Regulation of AML1/Runx1 gene is achieved by the use of a modern bi-component tetracycline inducible system. The design of the system enables fine tuning of levels of the AML1/Runx1 protein in cells. The influence of these AML1/Runx1 proteins will be studied in cultured ES cells as well as in developing mouse embryos and in the adult mouse. Two additional genetically modified mice which have fluorescent tagged genes controlled by AML1/Runx1 will also be used in this research to enable accurate identification of cells which express AML1 protein. Better understanding of stem cell regulation and the role of AML1 in this process will have potential implications for the development of protocols for practical regenerative medicine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Validation of biomarkers predicting clinical outcomes of umbilical cord blood transplantation
  • 批准号:
    MR/W029669/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $214.79万
  • 财政年份:
    2023
  • 负责人:
    Alexander Medvinsky
  • 依托单位:
Analysis of biomechanical forces in the embryonic development of haematopoietic stem cells
  • 批准号:
    BB/W003236/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $92.08万
  • 财政年份:
    2022
  • 负责人:
    Alexander Medvinsky
  • 依托单位:
UNDERSTANDING MOLECULAR MECHANISMS UNDERLYING DEVELOPMENT OF HIGHLY REGENERATIVE HUMAN HAEMATOPOIETIC STEM CELLS
  • 批准号:
    MR/V030043/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $91.8万
  • 财政年份:
    2021
  • 负责人:
    Alexander Medvinsky
  • 依托单位:
IDENTIFICATION OF A NOVEL ANGIOPOIETIN 2 SIGNALLING CENTRE IN THE EMBRYONIC HAEMATOPOIETIC STEM CELL NICHE
  • 批准号:
    MR/R018081/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $80.62万
  • 财政年份:
    2018
  • 负责人:
    Alexander Medvinsky
  • 依托单位:
国内基金
海外基金
AML1/ETO-FTO-IGFBP2轴在t(8;21)急性髓系白血病化疗耐药中的机理研究
  • 批准号:
    82070161
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2020
  • 负责人:
    李永辉
  • 依托单位:
环状RNA CDR1-AS通过上调融合基因AML1/ETO表达促进急性髓细胞白血病发生发展的分子机制
  • 批准号:
    81900161
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2019
  • 负责人:
    吕逸竹
  • 依托单位:
AML1/ETO融合基因通过APP和AML1/ETO9a协同C-KIT基因突变促发白血病的研究
  • 批准号:
    81500138
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2015
  • 负责人:
    余国攀
  • 依托单位:
mRNA甲基化调控儿童TEL/AML1阳性急性淋巴细胞白血病发生发展机制研究
  • 批准号:
    81470339
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2014
  • 负责人:
    竺晓凡
  • 依托单位: